Biomedicines,
Год журнала:
2025,
Номер
13(4), С. 951 - 951
Опубликована: Апрель 13, 2025
Cancer
remains
one
of
the
leading
causes
mortality
worldwide,
driving
need
for
innovative
approaches
in
research
and
treatment.
Artificial
intelligence
(AI)
has
emerged
as
a
powerful
tool
oncology,
with
potential
to
revolutionize
cancer
diagnosis,
treatment,
management.
This
paper
reviews
recent
advancements
AI
applications
within
research,
focusing
on
early
detection
through
computer-aided
personalized
treatment
strategies,
drug
discovery.
We
survey
AI-enhanced
diagnostic
explore
techniques
such
deep
learning,
well
integration
nanomedicine
immunotherapy
care.
Comparative
analyses
AI-based
models
versus
traditional
methods
are
presented,
highlighting
AI’s
superior
potential.
Additionally,
we
discuss
importance
integrating
social
determinants
health
optimize
Despite
these
advancements,
challenges
data
quality,
algorithmic
biases,
clinical
validation
remain,
limiting
widespread
adoption.
The
review
concludes
discussion
future
directions
emphasizing
its
reshape
care
by
enhancing
personalizing
treatments
targeted
therapies,
ultimately
improving
patient
outcomes.
Breathe,
Год журнала:
2024,
Номер
20(2), С. 230192 - 230192
Опубликована: Июнь 1, 2024
The
progress
in
lung
cancer
treatment
is
closely
interlinked
with
the
diagnostic
methods.
There
are
four
steps
before
commencing
treatment:
estimation
of
patient's
performance
status,
assessment
disease
stage
(tumour,
node,
metastasis),
recognition
histological
subtype,
and
detection
biomarkers.
resection
rate
<30%
>70%
patients
need
systemic
therapy,
which
individually
adjusted.
Accurate
diagnosis
very
important
it
basis
further
molecular
diagnosis.
In
many
cases
only
small
biopsy
samples
available
rules
for
their
defined
this
review.
use
immunochemistry
at
least
thyroid
transcription
factor
1
(TTF1)
p40
decisive
distinction
between
adenocarcinoma
squamous
cell
carcinoma.
Molecular
known
driver
mutations
necessary
introducing
targeted
therapy
multiplex
gene
panel
assays
using
next-generation
sequencing
recommended.
Immunotherapy
checkpoint
inhibitors
second
promising
method
best
results
tumours
high
programmed
death-ligand
(PD-L1)
expression
on
cells.
Finally,
determination
a
full
tumour
pattern
will
be
possible
artificial
intelligence
near
future.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(8), С. 4208 - 4208
Опубликована: Апрель 10, 2024
Lung
cancer
has
become
a
major
public
health
concern,
standing
as
the
leading
cause
of
cancer-related
deaths
worldwide.
Among
its
subtypes,
small-cell
lung
(SCLC)
is
characterized
by
aggressive
and
rapid
growth,
poor
differentiation,
neuroendocrine
features.
Typically,
SCLC
diagnosed
at
an
advanced
stage
(extensive
disease,
ED-SCLC),
with
distant
metastases,
strongly
associated
tobacco
smoking
prognosis.
Recent
clinical
trials,
such
CASPIAN
IMpower133,
have
demonstrated
promising
outcomes
incorporation
immune
checkpoint
inhibitors
in
first-line
chemotherapy,
to
prolonged
progression-free
survival
overall
patients
ED-SCLC
compared
standard
chemotherapy.
Other
studies
emphasized
potential
for
future
development
molecularly
targeted
therapies
patients,
including
IGF-1R,
DLL3,
BCL-2,
MYC,
or
PARP.
The
molecular
subdivision
based
on
transcriptomic
immunohistochemical
analyses
represents
significant
advancement
both
diagnostic
approaches
patients.
Specific
pathways
are
activated
within
distinct
transcriptome
subtypes
SCLC,
offering
personalized
treatment
strategies,
immunotherapies.
Such
tailored
hold
promise
significantly
improving
BMC Global and Public Health,
Год журнала:
2024,
Номер
2(1)
Опубликована: Май 17, 2024
Abstract
Current
strategies
to
promptly,
effectively,
and
equitably
screen
people
with
tuberculosis
(TB)
link
them
diagnosis
care
are
insufficient;
new
approaches
required
find
the
millions
of
around
world
TB
who
missed
each
year.
Interventions
also
need
be
designed
considering
how
interact
health
facilities
where
appropriate
should
suitable
for
use
in
community.
Here,
historical,
new,
reemerging
technologies
that
being
utilised
globally
discussed,
whilst
highlighting
we
evaluate
tests
is
just
as
important
themselves.
Technology in Cancer Research & Treatment,
Год журнала:
2024,
Номер
23
Опубликована: Янв. 1, 2024
Advancements
in
AI
have
notably
changed
cancer
research,
improving
patient
care
by
enhancing
detection,
survival
prediction,
and
treatment
efficacy.
This
review
covers
the
role
of
Machine
Learning,
Soft
Computing,
Deep
Learning
oncology,
explaining
key
concepts
algorithms
(like
SVM,
Naïve
Bayes,
CNN)
a
clear,
accessible
manner.
It
aims
to
make
advancements
understandable
broad
audience,
focusing
on
their
application
diagnosing,
classifying,
predicting
various
types,
thereby
underlining
AI's
potential
better
outcomes.
Moreover,
we
present
tabular
summary
most
significant
advances
from
literature,
offering
time-saving
resource
for
readers
grasp
each
study's
main
contributions.
The
remarkable
benefits
AI-powered
underscore
advancing
research
clinical
practice.
is
valuable
researchers
clinicians
interested
transformative
implications
care.
LATAM Revista Latinoamericana de Ciencias Sociales y Humanidades,
Год журнала:
2025,
Номер
6(1)
Опубликована: Янв. 16, 2025
El
cáncer
de
pulmón
en
la
actualidad
se
ha
convertido
patología
oncológica
diagnosticada
con
mayor
frecuencia,
y
además
figura
como
una
las
principales
causas
muerte.
Esta
enfermedad
tiene
tasa
elevada
mortalidad
que
relaciona
falta
síntomas
etapas
tempranas,
lo
ocasiona
confirmación
del
diagnóstico
suceda
avanzadas,
dando
resultado
opciones
tratamiento
disminuyan
ocasiones
estos
pacientes
no
lleguen
a
tener
curación.
En
el
caso
administre
manera
oportuna
supervivencia
10
años
es
88%.
Con
anteriormente
mencionado
buscado
maneras
mejorar
detección
temprana
pulmón,
entre
estas
mejoras
menciona
uso
inteligencia
artificial
esta
enfermedad.
Se
realizó
revisión
bibliográfica
diversas
bases
datos
científicas
objetivo
identificar
sintetizar
información
relevante
sobre
mediante
artificial.
La
conjunto
tomografía
computarizada
dosis
baja
mejora
tanto
sensibilidad
especificidad
oportuno
proporcionan
un
análisis
más
preciso
reducir
los
falsos
positivos
negativos.
Sin
embargo,
al
ser
nueva
herramienta
existe
control
regularizaciones
adecuadas
para
este
tipo
tecnologías.
Cancers,
Год журнала:
2025,
Номер
17(4), С. 621 - 621
Опубликована: Фев. 12, 2025
Background/Objectives:
Detecting
lung
nodules
on
computed
tomography
(CT)
images
is
critical
for
diagnosing
thoracic
cancers.
Deep
learning
models,
particularly
convolutional
neural
networks
(CNNs),
show
promise
in
automating
this
process.
This
systematic
review
and
meta-analysis
aim
to
evaluate
the
diagnostic
accuracy
of
these
focusing
lesion-wise
sensitivity
as
primary
metric.
Methods:
A
comprehensive
literature
search
was
conducted,
identifying
48
studies
published
up
7
November
2023.
The
pooled
performance
assessed
using
a
random-effects
model,
with
key
outcome.
Factors
influencing
model
performance,
including
participant
demographics,
dataset
privacy,
data
splitting
methods,
were
analyzed.
Methodological
rigor
maintained
through
Checklist
Artificial
Intelligence
Medical
Imaging
(CLAIM)
Quality
Assessment
Diagnostic
Accuracy
Studies-2
(QUADAS-2)
tools.
Trial
Registration:
registered
PROSPERO
under
CRD42023479887.
Results:
revealed
79%
(95%
CI:
72-86%)
independent
datasets
85%
83-88%)
across
all
datasets.
Variability
associated
characteristics
study
methodologies.
Conclusions:
While
deep
models
demonstrate
significant
potential
nodule
detection,
findings
highlight
need
more
diverse
datasets,
standardized
evaluation
protocols,
interventional
enhance
generalizability
clinical
applicability.
Further
research
necessary
validate
broader
patient
populations.
Algorithms,
Год журнала:
2025,
Номер
18(2), С. 96 - 96
Опубликована: Фев. 8, 2025
Computer
vision
and
artificial
intelligence
have
revolutionized
the
field
of
pathological
image
analysis,
enabling
faster
more
accurate
diagnostic
classification.
Deep
learning
architectures
like
convolutional
neural
networks
(CNNs),
shown
superior
performance
in
tasks
such
as
classification,
segmentation,
object
detection
pathology.
has
significantly
improved
accuracy
disease
diagnosis
healthcare.
By
leveraging
advanced
algorithms
machine
techniques,
computer
systems
can
analyze
medical
images
with
high
precision,
often
matching
or
even
surpassing
human
expert
performance.
In
pathology,
deep
models
been
trained
on
large
datasets
annotated
pathology
to
perform
cancer
diagnosis,
grading,
prognostication.
While
approaches
show
great
promise
challenges
remain,
including
issues
related
model
interpretability,
reliability,
generalization
across
diverse
patient
populations
imaging
settings.
Journal of medical imaging and radiation sciences,
Год журнала:
2025,
Номер
56(3), С. 101866 - 101866
Опубликована: Фев. 27, 2025
Modern
forms
of
Artificial
intelligence
(AI)
have
developed
in
radiology
over
the
past
few
years.
With
current
workforce
shortages,
both
and
radiography
professions,
AI
continues
to
prove
its
place
supporting
clinical
processes.
The
aim
scoping
review
was
investigate
existing
literature
on
topic
preference
use
artificial
interfaces
within
a
context.
Using
systematic
approach,
papers
were
chosen
against
an
inclusion
criterion
addressing
radiological
user
interface
preferences
be
included
review.
Arksey
O'Malley's
Levac's
framework
used
inform
procedural
steps
for
Four
databases
searched
including
MEDLINE
Ovid,
Scopus,
Web
Science
Engineering
Village.
Reliability
improved
through
involvement
three
researchers
select
criteria.
Six
identified
fit
criteria
preferences.
These
varied
methodologically
two
observational
studies,
simulated
testing
diagnostic
accuracy
study
multi-case
study.
evaluated
studies.
Mixed
responses
obtained
with
some
alignment
heatmap
image
overlays
highly
detailed
are
linked
higher
amongst
users.
Limited
exists
lack
research
evaluating
preference,
either
post
or
pre-deployment.
mix
methods
studies
indicated
that
there
is
not
yet
standardised
method
assessing
tool
design
radiology,
common
System
Usability
Scale
survey
conjunction
another
method.
There
also
response
when
considering
preferred
though
simple,
non-complicated
designs
suggested
ideal
by
participants.
Medical
imaging
essential
acceptability
technology
into
departments.
This
landscape
setting.
requirement
more
focussing
end
professional
their
explicit
need
further
field,
due
outcome
measures,
clear
findings
regarding
radiographers.
dearth
radiographers
small
sample
sizes
participants
these
identifies
mindset
shift
required
vendors
alike.